PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS

PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS

Detalhes bibliográficos
Main Authors:	van Staa, T, Cooper, C, Cohen, S, Reid, D, Barton, I, Laan, R
Formato:	Journal article
Publicado em:	2003

Registos relacionados

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Por: Van Staa, T, et al.
Publicado em: (2003)

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
Por: van Staa, T, et al.
Publicado em: (2003)

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
Por: van Staal, T, et al.
Publicado em: (2003)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
Por: Van Staa, T, et al.
Publicado em: (2004)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
Por: van Staa, T, et al.
Publicado em: (2007)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
Por: De Vries, F, et al.
Publicado em: (2007)

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.
Por: van Staa, T, et al.
Publicado em: (2005)

Risk of incident fracture is associated with dose, duration and recency of oral glucocorticoid exposure
Por: Robinson, DE, et al.
Publicado em: (2018)

Use of cyclical etidronate and prevention of non-vertebral fractures.
Por: van Staa, T, et al.
Publicado em: (1998)

Re: Use of cyclic etidronate and the prevention of non-vertebral fractures - Reply
Por: van Staa, T, et al.
Publicado em: (1998)

The limitations of using simple definitions of glucocorticoid exposure on the prediction of fracture risk
Por: Robinson, D, et al.
Publicado em: (2018)

Use of oral corticosteroids and risk of fractures.
Por: Van Staa, T, et al.
Publicado em: (2000)

Vertebral fractures predict subsequent fractures.
Por: Melton, L, et al.
Publicado em: (1999)

Risk of new vertebral fracture in the year following a fracture.
Por: Lindsay, R, et al.
Publicado em: (2001)

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
Por: de Vries, F, et al.
Publicado em: (2007)

Children and the risk of fractures caused by oral corticosteroids.
Por: van Staa, T, et al.
Publicado em: (2003)

The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: a cohort study
Por: Robinson, D, et al.
Publicado em: (2018)

Use of oral corticosteroids and risk of fractures. June, 2000.
Por: Van Staa, T, et al.
Publicado em: (2005)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
Por: Watts, N, et al.
Publicado em: (2004)

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
Por: De Vries, F, et al.
Publicado em: (2006)

The importance of vertebral fracture
Por: Reeve, J, et al.
Publicado em: (2003)

Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis
Por: Johnell, O, et al.
Publicado em: (2006)

VERTEBRAL FRACTURE RISK REDUCTION IS INDEPENDENT OF THE MAGNITUDE OF BMD CHANGE
Por: Adachi, J, et al.
Publicado em: (2004)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
Por: Watts, N, et al.
Publicado em: (2004)

CHARACTERISTICS OF PREVALENT VERTEBRAL DEFORMITY AND THE RISK OF INCIDENT VERTEBRAL FRACTURE
Por: Lunt, M, et al.
Publicado em: (2002)

QUALITY OF LIFE AND RADIOGRAPHIC VERTEBRAL FRACTURE
Por: O'Neill, T, et al.
Publicado em: (2002)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
Por: van Staa, T, et al.
Publicado em: (2000)

Missing an osteoporotic vertebral fracture
Por: Cheong, A.T., et al.
Publicado em: (2009)

Missing an osteoporotic vertebral fracture.
Por: Cheong, Ai Theng, et al.
Publicado em: (2009)

Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group.
Por: Black, D, et al.
Publicado em: (1999)

VERTEBRAL FRACTURES: DEFINITION, CLINICAL IMPACT AND EPIDEMIOLOGICAL CONSIDERATIONS
Por: Cooper, C
Publicado em: (2012)

A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population.
Por: Robinson, D, et al.
Publicado em: (2016)

Use of inhaled corticosteroids and risk of fractures.
Por: van Staa, T, et al.
Publicado em: (2001)

Understanding vertebral fracture risk in astronauts
Por: Burkhart, Katelyn A.
Publicado em: (2019)

Pharmaceutical treatment of symptomatic vertebral fractures in primary care.
Por: Torgerson, D, et al.
Publicado em: (2004)

Health care costs of women with symptomatic vertebral fractures.
Por: Puffer, S, et al.
Publicado em: (2004)

Health-related quality of life and radiographic vertebral fracture.
Por: Cockerill, W, et al.
Publicado em: (2004)

Use of statins and risk of fractures.
Por: van Staa, T, et al.
Publicado em: (2001)

Use of statins and risk of fractures.
Por: van Staa, T, et al.
Publicado em: (2000)

Does a fracture at one site predict later fractures at any other site?
Por: van Staa, T, et al.
Publicado em: (2001)